Deep Track Capital’s Acumen Pharmaceuticals ABOS Stock Holding History

Deep Track Capital’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,513,044	Closed	-$10.4M	–	61
2023 Q3	$10.4M	Sell	2,513,044 -1,403,317	-36%	-$8.67M	0.4%	49
2023 Q2	$18.8M	Sell	3,916,361 -35,639	-0.9%	-$171K	0.87%	32
2023 Q1	$16M	Hold	3,952,000	–	–	0.66%	41
2022 Q4	$21.3M	Buy	3,952,000 +173,182	+5%	+$1.16M	0.9%	38
2022 Q3	$37.9M	Buy	3,778,818 +678,818	+22%	+$3.89M	1.74%	20
2022 Q2	$14.6M	Buy	3,100,000 +500,902	+19%	+$1.88M	0.96%	32
2022 Q1	$10.2M	Buy	2,599,098 +666,058	+34%	+$3.62M	0.65%	38
2021 Q4	$13.1M	Buy	+1,933,040	New	+$21.2M	0.92%	39

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Deep Track Capital's ABOS Position: Q4 2023 in Review

Deep Track Capital sold out of Acumen Pharmaceuticals (ABOS) in Q4 2023, closing a stake of 2,513,044 shares — an estimated $10.4M sold.

Deep Track Capital first reported a position in ABOS in Q4 2021 and held it in 8 quarters. The position peaked at $37.9M in Q3 2022. 67 funds tracked by Wall St. Rank hold ABOS as of Q4 2023.

Deep Track Capital reported no remaining Acumen Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Deep Track Capital sold 2,513,044 Acumen Pharmaceuticals shares in Q4 2023, an estimated $10.4M.
Deep Track Capital first reported a position in Acumen Pharmaceuticals in Q4 2021 and held it in 8 quarters.
Deep Track Capital's Acumen Pharmaceuticals position peaked at $37.9M in Q3 2022.
67 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q4 2023.

Based on Deep Track Capital's 13F filing for Q4 2023, filed 14 Feb 2024.